Patents Assigned to MC SAF
  • Patent number: 11278627
    Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: March 22, 2022
    Assignee: MC SAF
    Inventors: Nicolas Joubert, Marie Claude Viaud-Massuard, Renaud Respaud